C57BL/6NCya-Sfrp4em1flox/Cya
Common Name:
Sfrp4-flox
Product ID:
S-CKO-05011
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Sfrp4-flox
Strain ID
CKOCMP-20379-Sfrp4-B6N-VA
Gene Name
Product ID
S-CKO-05011
Gene Alias
--
Background
C57BL/6NCya
NCBI ID
Modification
Conditional knockout
Chromosome
13
Phenotype
Document
Application
--
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Sfrp4em1flox/Cya mice (Catalog S-CKO-05011) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000002883
NCBI RefSeq
NM_016687
Target Region
Exon 4
Size of Effective Region
~1.8 kb
Detailed Document
Overview of Gene Research
Sfrp4, Secreted Frizzled Receptor Protein 4, is a decoy receptor for Wnt ligands, playing a crucial role in various biological processes. It is involved in the regulation of Wnt signaling pathways, which are essential for normal development, cell differentiation, and tissue homeostasis. Sfrp4 has significance in multiple biological systems, including the skeletal, reproductive, and cardiovascular systems, and its study using genetic models, like KO mouse models, has provided valuable insights into its functions [1-10].
In the skeletal system, Sfrp4 loss-of-function mutations cause Pyle disease, characterized by cortical bone thinning and increased fragility fractures despite increased trabecular bone density. On the endosteal surface, it represses non-canonical Wnt signaling to regulate endosteal resorption. In the periosteum, Sfrp4 is crucial for the expansion and differentiation of periosteal stem cell/progenitor cells. Sfrp4 deletion decreases the pool of Ctsk-lineage periosteal stem cells, impairs their multipotency, and hampers the periosteal response to bone injury [1,2].
In the ovary, Sfrp4-null female mice are hyperfertile due to decreased antral follicle atresia and enhanced ovulation rates. Sfrp4 promotes autophagy and blunts FSH responsiveness in ovarian granulosa cells through inhibition of AKT signaling. It also contributes to insulin-resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis [3,6,7].
In ApoE-deficient mice, overexpression of SFRP4 reduces atherosclerosis plaque formation [4]. In gastric cancer, elevated SFRP4 expression is linked to a poor prognosis and is associated with immune cell infiltration [5]. In endometrial carcinoma, PBX1 promotes SFRP4 transcription, which inhibits cell proliferation and epithelial-mesenchymal transition [8].
In conclusion, Sfrp4 is a key regulator in multiple biological processes. Studies using KO mouse models have revealed its important roles in bone development, female fertility, and disease conditions such as Pyle disease, polycystic ovary syndrome, atherosclerosis, and certain cancers. Understanding Sfrp4 functions provides potential therapeutic targets for these diseases.
References:
1. Chen, Ruiying, Baron, Roland, Gori, Francesca. 2022. Sfrp4 and the Biology of Cortical Bone. In Current osteoporosis reports, 20, 153-161. doi:10.1007/s11914-022-00727-w. https://pubmed.ncbi.nlm.nih.gov/35182301/
2. Chen, Ruiying, Dong, Han, Raval, Dhairya, Greenblatt, Matthew B, Gori, Francesca. 2023. Sfrp4 is required to maintain Ctsk-lineage periosteal stem cell niche function. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2312677120. doi:10.1073/pnas.2312677120. https://pubmed.ncbi.nlm.nih.gov/37931101/
3. Bérubé, Michael, Abedini, Atefeh, Lapointe, Evelyne, Zamberlam, Gustavo, Boerboom, Derek. 2024. SFRP4 promotes autophagy and blunts FSH responsiveness through inhibition of AKT signaling in ovarian granulosa cells. In Cell communication and signaling : CCS, 22, 396. doi:10.1186/s12964-024-01736-1. https://pubmed.ncbi.nlm.nih.gov/39138534/
4. Guan, Hua, Liu, Ting, Liu, Miaomiao, Shi, Tao, Guo, Fengwei. 2023. SFRP4 Reduces Atherosclerosis Plaque Formation in ApoE Deficient Mice. In Cardiology research and practice, 2023, 8302289. doi:10.1155/2023/8302289. https://pubmed.ncbi.nlm.nih.gov/37143778/
5. Yu, Pengcheng, He, Weiyang, Zhang, Yanqiang, Cheng, Xiangdong, Xu, Zhiyuan. 2022. SFRP4 Is a Potential Biomarker for the Prognosis and Immunotherapy for Gastric Cancer. In Journal of oncology, 2022, 8829649. doi:10.1155/2022/8829649. https://pubmed.ncbi.nlm.nih.gov/35847366/
6. Zamberlam, Gustavo, Lapointe, Evelyne, Abedini, Atefeh, DeMayo, Francesco J, Boerboom, Derek. . SFRP4 Is a Negative Regulator of Ovarian Follicle Development and Female Fertility. In Endocrinology, 160, 1561-1572. doi:10.1210/en.2019-00212. https://pubmed.ncbi.nlm.nih.gov/30942852/
7. Wang, Jiangxia, Gui, Runlin, Li, Yang, Fan, Xiaobin, Xiong, Yuyan. 2024. SFRP4 contributes to insulin resistance-induced polycystic ovary syndrome by triggering ovarian granulosa cell hyperandrogenism and apoptosis through the nuclear β-catenin/IL-6 signaling axis. In Biochimica et biophysica acta. Molecular cell research, 1871, 119822. doi:10.1016/j.bbamcr.2024.119822. https://pubmed.ncbi.nlm.nih.gov/39159685/
8. Guo, Liwen, Chen, Huihua, Chen, Jinguo, Chen, Zichun, Cao, Luoyuan. 2023. PBX1-promoted SFRP4 transcription inhibits cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma. In Tissue & cell, 82, 102083. doi:10.1016/j.tice.2023.102083. https://pubmed.ncbi.nlm.nih.gov/37054536/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen